There is strong potential for growth in the global pneumonia therapeutics market. The growing healthcare expenditure across developed nations, such as Germany, Japan, Brazil, and the United States demonstrates an increasing investment in clinical research and development, which is driving the growth of the global pneumonia therapeutics market.